K062864

Substantially Equivalent

MASTALEX -MRSA, MODEL RST501

Applicant: Mast Group , Ltd.
Product code: MYI
Advisory panel: Microbiology
Date received: 2006-09-25
Decision date: 2006-10-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bootle, Merseyside, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.